ArticleFrontiers in cardiovascular medicine2026
Application of the combined technique of novel transseptal puncture guidewire and steerable sheath in left atrial appendage occlusion: a preliminary feasibility case series.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Transseptal puncture (TSP) is a critical step in left atrial appendage occlusion (LAAO) but presents certain technical challenges. Conventional puncture needles, due to their inherent rigidity, often cause unpredictable needle tip "bouncing" or upward migration at the moment of septal puncture, resulting in a high or suboptimal puncture site, which subsequently compromises the coaxial alignment between the sheath and the left atrial appendage (LAA). This study aims to evaluate the safety and feasibility of the novel transseptal puncture guidewire Accusafe™ used in combination with a steerable sheath Navigo™. Methods: In this case series, 20 consecutive patients undergoing a one-stop procedure (LAAO combined with atrial fibrillation ablation) were enrolled. The first 10 patients underwent conventional transseptal puncture, while the latter 10 underwent transseptal puncture using Accusafe™. The primary endpoints included first-pass puncture success rate, incidence of post-puncture site migration, and coaxiality assessed by the angle between the delivery sheath and the central axis of the LAA on angiography. Results: Transseptal puncture was successfully performed in all patients. The application of Accusafe™ in combination with a steerable sheath significantly reduced sheath migration, achieving a first-pass puncture success rate of 100%. Furthermore, Accusafe™ significantly improved sheath-LAA coaxiality, effectively simplified the occluder delivery and deployment process, shortened procedure time, and ensured an ideal occlusion outcome. Conclusion: Transseptal puncture via the Accusafe™ guidewire with steerable sheath improves first-pass puncture success rate, enhances puncture site accuracy, and optimizes sheath-LAA central axis coaxiality, thereby improving procedural efficiency and occlusion efficacy. These findings support further validation of its clinical value in larger, randomized controlled studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.